Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C W Lynde

Showing results (51-60 of 54) with videos related to

Pageof 6
Sort By:
You have reached the last page of results.This site can display upto 54 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 22, 2017
Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized studyR Bissonnette, R Haydey, L A Rosoph, et al.
The Journal of Dermatological Treatment|January 31, 2020
Topical treatment of psoriasis: questionnaire results on topical therapy as long-term continuous treatment and use on specific body sitesT Hoegsberg, L Iversen, M M Lange, et al.
The British Journal of Dermatology|February 26, 2008
Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trialT Ruzicka, C W Lynde, G B E Jemec, et al.
Journal of the American Academy of Dermatology|October 19, 2001
The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibodyK Papp, R Bissonnette, J G Krueger, et al.
Pageof 6

Showing results (51-60 of 54) with videos related to

Sort By:
Pageof 6
You have reached the last page of results.This site can display upto 54 results.
Journal of the European Academy of Dermatology and Venereology : JEADV|October 22, 2017
Apremilast for the treatment of moderate-to-severe palmoplantar psoriasis: results from a double-blind, placebo-controlled, randomized studyR Bissonnette, R Haydey, L A Rosoph, et al.
The Journal of Dermatological Treatment|January 31, 2020
Topical treatment of psoriasis: questionnaire results on topical therapy as long-term continuous treatment and use on specific body sitesT Hoegsberg, L Iversen, M M Lange, et al.
The British Journal of Dermatology|February 26, 2008
Efficacy and safety of oral alitretinoin (9-cis retinoic acid) in patients with severe chronic hand eczema refractory to topical corticosteroids: results of a randomized, double-blind, placebo-controlled, multicentre trialT Ruzicka, C W Lynde, G B E Jemec, et al.
Journal of the American Academy of Dermatology|October 19, 2001
The treatment of moderate to severe psoriasis with a new anti-CD11a monoclonal antibodyK Papp, R Bissonnette, J G Krueger, et al.
Pageof 6